首页> 外文期刊>Cellular and molecular biology >Effect of HOTAIR rs12826786 and rs1899663 polymorphisms on lung cancer susceptibility and clinicopathological characteristics in a turkish population: a hospital-based case-control study
【24h】

Effect of HOTAIR rs12826786 and rs1899663 polymorphisms on lung cancer susceptibility and clinicopathological characteristics in a turkish population: a hospital-based case-control study

机译:HotaiR12826786和RS1899663对土耳其人群肺癌易感性和临床病理特征的影响:基于医院的案例控制研究

获取原文
获取原文并翻译 | 示例
           

摘要

Overexpression of Hox transcript antisense intergenic RNA (HOTAIR), a long non-coding RNA (lncRNA), is associated with tumorigenesis and multiple cancer types including lung cancer. In this study, the association between two HOTAIR single nucleotide polymorphisms (SNPs) (rs12826786 and rs1899663) on the risk and clinical characteristics of lung cancer in a Turkish population was investigated. We genotyped HOTAIR rs12826786 and rs1899663 polymorphisms in 180 Turkish people including 87 lung cancer patients (71 males and 16 females) and 93 age-matched healthy controls (67 males and 26 females) by a TaqMan real-time polymerase chain reaction method. The mean age value of the lung cancer patients and control subjects were 59.27 +/- 10.55 and 61.77 +/- 12.00, respectively. We found that none of the two HOTAIR polymorphisms (rs12826786 TC, rs1899663AC) has any significant association with the increased risk of lung cancer in any type of inheritance genetic models. However, our research indicated that carriers of Trs12826786/Crs1899663 (ht3) (P = 0.03) had an increased risk of lung cancer susceptibility.
机译:Hox转录物反义基因间RNA(HOTAIR)是一种长非编码RNA(lncRNA),其过度表达与肿瘤发生和包括肺癌在内的多种癌症类型有关。在这项研究中,研究了土耳其人群中两种HOTAIR单核苷酸多态性(rs12826786和rs1899663)与肺癌风险和临床特征之间的关联。我们采用TaqMan实时聚合酶链反应方法对180名土耳其人群中的HOTAIR rs12826786和rs1899663多态性进行了基因分型,其中包括87名肺癌患者(71名男性和16名女性)和93名年龄匹配的健康对照组(67名男性和26名女性)。肺癌患者和对照组的平均年龄值分别为59.27+/-10.55和61.77+/-12.00。我们发现,在任何类型的遗传遗传模型中,两种HOTAIR多态性(rs12826786 T;C、rs1899663A;C)均与肺癌风险增加无显著关联。然而,我们的研究表明,Trs12826786/Crs1899663(ht3)(P=0.03)携带者患肺癌的风险增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号